Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/19599
Title: ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
Authors: Luk, Ian Y;Reehorst, Camilla M;Mariadason, John M
Affiliation: Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, Victoria 3086, Australia
Issue Date: 30-Aug-2018
EDate: 2018-08-30
Citation: Molecules (Basel, Switzerland) 2018; 23(9): E2191
Abstract: The epithelium-specific ETS (ESE) transcription factors (ELF3, ELF5, EHF and SPDEF) are defined by their highly conserved ETS DNA binding domain and predominant epithelial-specific expression profile. ESE transcription factors maintain normal cell homeostasis and differentiation of a number of epithelial tissues, and their genetic alteration and deregulated expression has been linked to the progression of several epithelial cancers. Herein we review the normal function of the ESE transcription factors, the mechanisms by which they are dysregulated in cancers, and the current evidence for their role in cancer progression. Finally, we discuss potential therapeutic strategies for targeting or reactivating these factors as a novel means of cancer treatment.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19599
DOI: 10.3390/molecules23092191
ORCID: 0000-0001-9123-7684
PubMed URL: 30200227
Type: Journal Article
Review
Subjects: EHF
ELF3
ELF5
SPDEF
Cancer
transcription factor
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.